PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 47: Articles 23001-23500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Family planning in Mexico 1982 (antecedents; present situation, future; perspectives. [La planificacion familiar en Mexico 1982 (antecedentes; situacion actual; perspectivas a futuro)]
  2. Family planning in rural Egypt 1980. A report on the results of the Egypt Contraceptive Prevalence Survey.
  3. Family planning in Spain.
  4. Family planning in the 1980's: challenges and opportunities: report of the International Conference on Family Planning in the 1980's, Jakarta, Indonesia, 26-30 April 1981.
  5. Family planning in the Eastern Caribbean: a report on the formulation of population policy.
  6. Family planning in the Third World: conceptual considerations and an application to rural Thailand.
  7. Family planning needs of native people in Canada: a background paper.
  8. Family planning perspectives.
  9. Family planning procedure manual for nurse-midwives 1982.
  10. Family planning procedure manual for nurse-midwives. [Planning familial, manuel technique pour infirmieres sage-femmes.]
  11. Family planning program performance and its determinants: a cross-national study of Asian programs [tables]
  12. Family planning program, Taiwan area, Republic of China, July 1979-June 1981.
  13. Family planning programmes in Asian countries: the Indonesian experience.
  14. Family planning programmes.
  15. Family planning programs. 1. Developing countries.
  16. Family planning programs. 2. Nonclinical programs.
  17. Family planning programs. 3. United States.
  18. Family planning programs. 4. Management and evaluation.
  19. Family planning programs. 5. Effects on fertility.
  20. Family planning research.
  21. Family planning services for southeast Asian refugees.
  22. Family planning services in rural Tunisia: a case study.
  23. Family planning Social Marketing Project, Bangladesh: a profile [brochure]
  24. Family planning social marketing project. Consumer study.
  25. A family planning study in Kuala Pilah, Peninsular Malaysia.
  26. Family planning work in Sweden.
  27. Family planning, teenagers, parents and government.
  28. Family planning--male responsibility campaign.
  29. Family planning.
  30. Family Planning.
  31. Family planning. [Familienplanung.]
  32. Family planning. [Planejamento familiar.]
  33. Family planning. Contraception, sterilization, abortion. [Famielenplanung. Kontrazeption, Sterilisation, Abort.]
  34. Family planning: an integral part of mental health care.
  35. Family planning: obstacles to overcome.
  36. Family planning: Ondo State of Nigeria.
  37. Family planning: the benefits and costs.
  38. Family size intentions and attitudes to contraception: Australian and Papua New Guinean high school youth.
  39. Female contraception: hormonal methods. [La contraception feminine: methodes hormonales.]
  40. Female phase fazer: new birth control?
  41. Fertility after discontinuation of oral contraceptives.
  42. Fertility after intrauterine contraception discontinuation.
  43. Fertility and contraception in Colombia: determinants and implications. [Fecundidad y anticoncepcion en Colombia: determinantes e implicaciones.]
  44. Fertility and family planning among two tribal communities of Uttar Pradesh.
  45. Fertility and family planning in Barbados: findings from the Contraceptive Prevalence Survey 1980-81.
  46. Fertility and family planning in Daveyton: a survey of women. [Fertiliteit en gesinsbeplanning in Daveyton: opname onder vroue.]
  47. Fertility and family planning in Daveyton: survey among men.
  48. Fertility and family planning in the 1970s: the national survey of family growth.
  49. Fertility and family planning in the small island countries of the ESCAP/SPC region.
  50. Fertility awareness: a revolution in birth control?
  51. Fertility patterns in Kerala, India: an assessment of the role of modernization and family planning in determining fertility norms and behavior.
  52. Fertility studies and influences of wife's employment on family decision making patterns: a family planning perspective.
  53. Fertility, family planning and technology of agricultural production.
  54. Final report to the Regional Council on the Migrant and Planned Parenthood Project.
  55. Final report: Women in Management Seminar-Workshop IX on "Planning and Management of Service Delivery Programs in Family Planning, Health and Development" May 10 to June 11, 1982.
  56. First regional contraceptive social marketing program.
  57. Five hundred females from Guadeloupe and their attitudes to contraception (author's transl) [500 femmes guadeloupeennes et la contraception.]
  58. Folklore information from Assam for family planning and birth control.
  59. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
  60. FPA Medical Advisory Panel Statement: post-coital contraception.
  61. The fragmentation of reproductive health policy: the case of maternity care and birth control.
  62. From a revolt to a struggle: 25 years of the history of family planning. [D'une revolte a une lutte: 25 ans d'histoire du planning familial.]
  63. From contraception to cancer: a review of the therapeutic applications of LHRH analogues as antitumor agents.
  64. From macho to mutuality: helping young men make effective decisions about sex, contraception, and pregnancy.
  65. From worms and family planning to development by the people: a case of technical assistance through integrated family planning projects.
  66. Frontier issues in the evaluation of family programmes: programme relationship to non-programme sector; evaluation of integrated service programme; and linkages of social change to family planning.
  67. Future perspectives in contraception. [Les perspectives d'avenir de la contraception.]
  68. Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids.
  69. General guidelines for the formulation of standards in family planning matters. [Lineamientos generales para formulacion de normas institucionales en materia de planificacion familiar.]
  70. Genital actinomycosis as a complication of an intrauterine contraceptive device and curettage of the uterine cavity. [Promienica narzadu rodnego jako powiklanie po zastosowaniu wewnatrzmacicznej wkladki antykoncepcyjnej i po wylyzeczkowaniu jamy macicy.]
  71. Genito-urinary symptoms and signs in women using different contraceptive methods.
  72. Gossypol as oral contraceptive for male: trial case report.
  73. Guide to resources for family planning leaders. [Guide de ressources a l'intention des animatrices de planning familial.]
  74. Health and contraception. [Sante et contraception.]
  75. Health and family planning activities in the demonstration union.
  76. Health and family planning in rural areas.
  77. Health and family planning in the rural environment. [Salud y planificacion familiar en el medio rural.]
  78. Health aspects of family planning: a guide to resources in the United States.
  79. Hematologic abnormalities in adolescents who take oral contraceptive pills.
  80. Hepatic adenoma associated with oral contraceptives.
  81. Hepatocellular carcinoma associated with oral contraceptive use and pregnancy.
  82. Hepatocellular carcinoma in women: probable lack of etiologic association with oral contraceptive steroids.
  83. Histochemical changes in the endometrium after the use of IUCD and oral contraceptives.
  84. History of contraception through official texts. [L'histoire de la contraception a travers les textes officiels.]
  85. History of family planning activities in Gomia.
  86. Hormonal contraception and hypertension. [Hormonale Kontrazeption und Hypertonie.]
  87. Hormonal contraception and some biochemical indicators with special attention to proteins (author's transl) [Hormonalni antikoncepce a nektere biochemicke ukazatele se zvlastnim zretelem k bilkovinam.]
  88. Hormonal contraception for men: acceptability and effects on sexuality.
  89. Hormonal contraception in juveniles--beginning at what age? [Hormonale Kontrazeption bei Jugendlichen-ab wann?]
  90. Hormonal contraception.
  91. Hormonal contraceptives relevant to family planning? (editorial) [Hormonale Kontrazeptiva fur Familienplanung relevant?]
  92. Hospital family planning education and referral services: Michigan survey.
  93. Household distribution of contraceptives in rural Haiti, January 1978-January 1982. [Distribution de contraceptifs a demoicle en milieu rural Haitien, Janvier 1978-Janvier 1982.]
  94. How to carry out work on family planning after adopting production responsibility systems in rural areas.
  95. Hyperestrogenic state under low-dose progestagen-only mini-pill (author's transl) [Hyperestrogenie sous contraception par micropilule progestative.]
  96. Hypertension and oral contraceptives.
  97. Hypertension associated with oral contraceptive agents and hypertension in pregnancy.
  98. Hypophyseotropic effects of ethinyl estradiol and contraceptive progestins.
  99. An idolized pill: a pill to be gilded...or resistance to oral contraception. [Une pilule adoree--a dorer...ou les resistances a la contraception orale.]
  100. Immunologic contraception. [Immunologicheskii metod kontratseptsii.]
  101. Impact evaluation of the Texas Department of Human Resources' Family Planning Program.
  102. The impact of breastfeeding and pregnancy status of household contraceptive distribution in rural Haiti.
  103. The impact of government policies on the family planning programme of the Republic of Singapore.
  104. The impact of religion, socio-economic status, and degree of religiosity on family planning among Moslems and Baha'is in Iran: a pilot survey research.
  105. The impact of the Title X program on state Title XX expenditures for family planning: some preliminary findings.
  106. Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids.
  107. Implants vs. long-acting injectable contraceptives--pros and cons.
  108. An improved application of methods of measuring the impact of family planning on fertility: the case of Tunisia, 1956-1979.
  109. Improvement in arthritis symptoms with oral contraceptives? [Answer to question]
  110. Incentives and disincentives in surgical contraception.
  111. Incentives and disincentives to promote family planning.
  112. An Indian experiment in grassroots family planning.
  113. Indications and medical survey of long acting progestatives used for contraception (author's transl) [Indications et surveillance d'une contraception par progestatifs retard.]
  114. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
  115. Induced abortion and contraceptive method choice among urban Japanese marrieds.
  116. Induced abortion in maternal and child health centres in a general family planning programme in Cap Bon, Tunisia.
  117. Industrial Settings and Family Planning Promotion and and Services in Bolivia, an Operations Research Project. Proposal.
  118. Infectious complications associated with the intrauterine contraceptive device.
  119. Inferior vena cava stenosis and Budd-Chiari syndrome in a woman taking oral contraceptives.
  120. Infertility following discontinuation of different contraceptive methods.
  121. Influence of combined oral contraceptives on prolactin blood levels (author's transl) [Influencia dos anticoncepcionais orais combinados no nivel sanguineo de prolactina.]
  122. Influence of combined oral steroid contraceptives on the LHRH/TRH-triple stimulation of pituitary secretion.
  123. Influence of contraceptives on gamma glutamyltransferase activity.
  124. Influence of counselling in postabortal contraception.
  125. Influence of estrogen content of oral contraceptives and consumption of sucrose on blood parameters.
  126. Influence of hormonal contraception on the maturation process of the hypothalamo-pituitary-ovarian axis.
  127. Influence of mass media on the attitude towards oral contraceptives.
  128. Influence of oral contraceptive therapy on lupus nephropathy (author's transl) [Influence de la contraception hormale sur l'evolutivite des nephropathies lupiques.]
  129. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.
  130. The influence of oral contraceptives on gingival status. [Influence des contraceptifs oraux sur l'etat gingival.]
  131. The influence of oral contraceptives on lipoprotein status (author's transl) [Lipoproteinstatus unter oralen Kontrazeptiva.]
  132. The influence of oral contraceptives on the composition of bile.
  133. The influence of oral contraceptives on the metabolism of methaqualone in man.
  134. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation.
  135. Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam.
  136. The influence that the quantities of ethinyloestradiol and the type of progestogen in oral contraceptives have on the hypertriglyceride state of those taking the contraceptives (author's trans) [Influence de la dose d ethinyl-estradiol de et la nature du progestatif sur 1: hypertriglyceridemie induite par les contraceptifs oraux.]
  137. Informed consent and contraceptive choice.
  138. Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent.
  139. Inhibition of lactation by contraceptive (letter) [A szoptato anya tejenek elapadasa es a fogamzasgatlok.]
  140. Initiating natural family planning fertility awareness method instruction in a feminist clinic.
  141. Injectable contraception.
  142. Injectable contraceptives.
  143. Injectable contraceptives: safe and effective.
  144. Injectable hormonal contraceptives: technical and safety aspects.
  145. Injectable microcapsule contraceptive system.
  146. Injectable norethisterone enanthate contraception: absence of an effect on oral glucose tolerance.
  147. Innovative approaches for reaching young people in health and family planning programs.
  148. Integrated family planning parasite control and nutrition program: the Grobogan field study.
  149. The integrated family planning program--concept, implementation and development.
  150. Integrated family planning programs: rationale, concepts and methodology for evaluation.
  151. An investigation into the quality of service provided by telephone hotlines for family planning services.
  152. An investigation of the relationship between sex role orientation, level of assertiveness, affective orientation to sexuality and a model of contraceptive behavior.
  153. Involvement, communication behavior and family planning diffusion.
  154. Involving people in family planning programme: Indian strategy.
  155. Iowa Family Planning Program.
  156. Is the combination of oral contraceptive and triacetyloleandomycine specially hepatotoxic? (author's transl)] [letter. [Oestroprogestatifs et triacetyloleandomycine: association icterigene?]
  157. Islam seen as compatible with family planning.
  158. Islamic view of family life. Islamic approach to family welfare. Proceedings of the Work Camp for Family Planning, Dhaka, March 22-25, 1982.
  159. Issues in family planning clinic management.
  160. Issues in integrated family planning and health programs.
  161. Issues in the comparative analysis of techniques for evaluating family planning programmes.
  162. It's your choice: a personal guide to birth control methods for women...and men too]
  163. Joint report on the future role of United Nations System assistance in family planning research: the case of Senegal. [Rapport conjoint sur le role future de l'assistance du systeme des Nations Unies dans la recherche en planification familiale: cas du Senegal.]
  164. Kenya's Maternal Child Health Family Planning Program (Family Health)
  165. Knowledge and attitudes of family planning in Khartoum Province, Sudan.
  166. Knowledge and use of contraception in twenty developing countries.
  167. Knowledge concerning the family planning clinic among the female population of Milan: studies of a group of 959 puerperas. [La conoscenza del consultorio familiare nella popolazione feminile milanese; indagine su un gruppo di 959 puerpere.]
  168. Knowledge of reproduction, attitudes toward contraception, and self-esteem of teenage pregnant girls in southeastern Michigan.
  169. Knowledge, attitude and practice in family planning and desired family size in Thailand.
  170. Knowledge, attitude and practice of family planning in Eastern Nigeria: implications, prospects and suggestions.
  171. Lack of hepatogenotoxicity of oral contraceptive steroids.
  172. Lactation and lactation related variables, contraception and fertility: an overview of data problems and world trends.
  173. Laparoscopic removal of translocated intrauterine contraceptive devices.
  174. Laws, policies and family planning: a handbook. [Leyes, politicas y planificacion familiar: un manual.]
  175. Laxatives and hormonal contraceptives. [Laxantien und hormonale Kontrazeptiva.]
  176. Legal and ethical considerations for doctors in family planning.
  177. Lesions of the cervix uteri according to the type of contraception. Statistical study of 1388 cervicovaginal smears (letter) [Lesions du col uterin selon le type de contraception. Etude statistique de 1388 frottis cervico-vaginaux.]
  178. LHRH antibodies: their use in the study of hypothalamic LHRH and testicular LHRH-like material, and possible contraceptive applications.
  179. Lipoproteins and the estrogenicity of oral contraceptives.

     

  180. Liver adenoma and focal nodular hyperplasia in a woman using oral contraceptives. [Association d'un adenome hepatocellulaire et d'une hyperplasie nodulaire focale du foie chez une femme sous contraceptifs oraux.]
  181. Liver adenoma with granulomas. The appearance of granulomas in oral contraceptive-related hepatocellular adenoma and in the surrounding nontumorous liver.
  182. Liver diseases when using hormonal contraceptives (author's transl) [Lebererkrankungen durch hormonelle Kontrazeptiva.]
  183. Liver lesions and oral contraceptives [letter]
  184. Liver tumors and oral contraceptives.
  185. Liver tumors and oral contraceptives. Anatomo-clinical and etiologic considerations on the subject of three case histories. [Proliferations hepatiques et contraception orale. Considerations anatomo-cliniques et etiologiques a propos de trois observations.]
  186. Local production of contraceptives in developing countries.
  187. Long acting injectable hormonal contraceptives.
  188. Long-acting injectable steroid contraceptives.
  189. Long-term controls of contraceptive agents in general practice and their effect on family planning. [Langzeitkontrollen von antikonzeptionellen Mitteln in der Allgemeinpraxis und ihre Auswirkungen auf die Familienplanung.]
  190. Long-term effects of the combined oral contraceptive pill on carbohydrate and lipid metabolism in Singapore women--a cross-sectional study.
  191. Long-term oral contraceptive use and the risk of breast cancer: the Centers for Disease Control Cancer and Steroid Hormone Study.
  192. Longitudinal study of the effect of hormonal contraceptives on clinical parameters of the gingiva. 1. Gingivitis indices and plaque index (author's transl) [Longitudinal-Studie uber den Einfluss hormoneller Kontrazeptiva auf klinische Parameter der Gingiva. 1. Mitteilung: Gingivitisindizes und Plaque-Index.]
  193. Making decisions under stress: the case of adolescents seeking birth control.
  194. Malaysian integration project progress report and parasite control as a point of entry for family planning health education and community participation.
  195. Male adolescent psychosexual development: the influence of significant others on contraceptive behavior.
  196. Male attitudes toward family planning in the Sudan.
  197. Male contraception and its perspectives. [La contraception masculine et ses perspectives.]
  198. Male contraception. [Contraception masculine.]
  199. Male contraception. [La contraception masculine.]
  200. Male contraception: a future? [L'approche masculine de la contraception, au avenir?]
  201. Male contraception: clinical trials.
  202. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 microgram oestrogen pill.
  203. Malthusian paradigm and the issue of compulsion in family planning.
  204. Management constraints of family planning programmes in South Asia, survey report.
  205. Managing the marketing of birth control in India.
  206. The manly art of contraception.
  207. The Margaret Sanger Center: final report on the International Family Planning Nurse Practitioner Training Program, Group 82, February 22--April 30, 1982.
  208. Marked alterations in prednisolone elimination for women taking oral contraceptives [abstract]
  209. Marriage, fertility and family planning. Summary of the major findings of the Egyptian Rural Fertility Survey 1979.
  210. Marriage, sexuality, and contraception in the British middle class, 1918-1939: the correspondence of Marie Stopes.
  211. Massive and painful liver enlargement, sinusoidal dilatation, and long-term administration of oral contraceptives (letter) [Hepatomegalie massive douloureuse, dilatation sinusoidale et prise prolongee d'oestroprogestatifs.]
  212. Maternal and child health and family planning is an island village locality.
  213. Maternal and child health benefits of family planning.
  214. Maternal child health-family planning survey, Paraiba State, Brazil--1980. English language report.
  215. Maternal nutrition, breast feeding, and contraception.
  216. Maximizing the benefits and minimizing the risks of oral contraceptive use [tables]
  217. Measuring family planning acceptance by the criterion of excess children.
  218. Measuring family planning effort: indices of family planning inputs.
  219. The medical auxiliary and contraception. [L'auxiliaire medicale dans la contraception.]
  220. Meeting of agencies conducting or directly supporting research on the biomedical aspects of family planning, Geneva, 7-8 Sept. 1981: report.
  221. Meeting of agencies conducting or directly supporting research on the biomedical aspects of family planning, Geneva, 7-8 September 1981.
  222. Menstrual disturbance and injectable contraceptives.
  223. The metabolic effects of hormonal contraceptives.
  224. Metabolism of injectable formulations of contraceptive steroids in obese and thin women.
  225. Method discontinuance in teenage women: implications for teen contraceptive programs.
  226. Methodological Directives No. 14 of 10 June 1977 on contraception [excerpts]
  227. Methods of contraceptive. Educational chart at the University Gynecological Clinic, Mannheim. [Methoden zur Empfangnisverhutung. Aufklarungsblatt der Universitats-Frauenklinik Mannheim.]
  228. Metoprolol pharmacokinetics and the oral contraceptive pill.
  229. Microcirculation and oral contraceptives (author's transl) [Microcirculation et contraceptifs oraux.]
  230. Mid-term evaluation of USAID Family Planning Services Project in Bangladesh (388-0050)
  231. Mid-wives and non-physicians in family planning clinics reference: New Zealand.
  232. Migraine and oral contraceptives.
  233. Migrant-nonmigrant differentials in socioeconomic status, fertility and family planning in Nepal.
  234. Misconceptions about family planning, contraception and sex education, sexual abuse and congenital abnormalities of the genital system.
  235. Mitral valve prolapse and oral contraceptive therapy [letter]
  236. Mobile family planning clinic, McCormick Hospital.
  237. A model for analysis of the Malaysian family planning programme.
  238. A model for estimating delay to return to fertility following discontinuation of different contraceptives.
  239. Modernity value orientations, fertility and family planning.
  240. Mood changes as reported by women taking the oral contraceptive pill.
  241. Moral and psychological aspects of coitus and contraception.
  242. Morality of contraception.
  243. Mortality among young black contraceptive users (working draft)
  244. The mortality risk of voluntary surgical contraception.
  245. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as a postcoital contraceptive agent.
  246. A multilevel model of family planning availability and contraceptive use in rural Thailand.
  247. Multiple pregnancy and fetal abnormalities in association with oral contraceptive usage.
  248. The National Family Planning Program in Indonesia: a management approach to a complex social issue.
  249. The National Inventory of Family Planning Services: 1978 survey results.
  250. The national program for family planning: evaluation for the period 80-81. [Programa nacional de planificacion familiar: evaluation del periodo 1980-1981.]
  251. National survey on contraception from the woman's viewpoint. [Enquete nationale sur "la contraception vue du cote des femmes".]
  252. A natural contraceptive.
  253. Natural family planning at the grassroots.
  254. Natural family planning including breast-feeding.
  255. Natural family planning methods [letter]
  256. The natural family planning teacher.
  257. Natural family planning--a way of life.
  258. Natural family planning--the hidden agenda.
  259. Natural family planning--the Rabbinic position vis-a-vis the Catholic position.
  260. Natural family planning.
  261. Natural family planning.
  262. Natural family planning: a comparison of continuers and discontinuers.
  263. Natural family planning: a review.
  264. Natural family planning: an analysis of change in procreative intention.
  265. Natural family planning: official definitions.
  266. Natural family planning: personal aspects.
  267. Natural law and artificial contraception: a critical comparison of the views of three recent Popes, Paul Ramsey and Charles Curran.
  268. Natural means of birth control. [Les moyens naturels de regulation des naissances.]
  269. The need for family planning in psychiatric hospitals.
  270. New approach of family planning as a part of family health.
  271. A new class of contraceptives?
  272. A new decade of fertility and family planning in Thailand: 1981 Contraceptive Prevalence Survey.
  273. New progestagens for oral contraception.
  274. New risk-benefit evaluation permits flexible use of hormonal contraception. The conversion from high dose to low dose oral contraceptives is unproblematic and beneficial for all age groups. Report on the "International Symposium: Current Issues in Hormonal Contraception," 13 Feb 1982, Berlin, Freie Universitat Berlin, Klinikum Steglitz. [Neue Risiko-Nutzen-Einschatzung erlaubt flexiblere Handhabung der hormonalen Kontrazeption. Die Umstellung von hoher dosierten oralen Kontraceptiva auf niedriger dosierte Praparate ist in allen altersgruppen unproblematisch und vorteilhaft. Bericht uber das "Internationale Symposium: Aktuelle Aspekte der hormonalen Kontrazeption" am 13. 2. 1982 in Berlin, Freie.]
  275. A new two-step combination preparation for hormonal contraception (author's transl) [Ein neues, zweistufiges Kombinationsparparat zur hormonellen Kontrazaption.]
  276. New vaginal contraceptives--pharmaceutic and biologic considerations.
  277. New Zealand Family Planning Association policy [letter]
  278. No significant change noted in sister chromatid exchanges, chromosomal aberrations and satellite associations in women taking oral contraceptive, methylnorethindrone compositae for a long term.
  279. Non surgical permanent contraception: prospects.
  280. Non-hormonal methods of female contraception. [Les methodes non hormonales de la contraception feminine.]
  281. The noncontraceptive health benefits from oral contraceptive use.
  282. Noncontraceptive health benefits of oral steroidal contraceptives.
  283. The nonspermicide honeycup method of contraception.
  284. Normal sister-chromatid exchanges in oral contraceptive users.
  285. Normative and psychic costs of contraception [draft]
  286. A note on the 1978 Turkish Fertility Survey: a problem defining contraceptive prevalence and consequent confusion.
  287. A note on the concept of potential fertility and its application in the estimation of the fertility impact of family planning programmes.
  288. Notes on contraception and sterilization in cardiac patients. [Il punto sulla contraccezione e sterilizzazione nelle cardiopatiche.]
  289. Novel mode of contraception using polymeric hydrogels. I.
  290. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
  291. Nuptiality, fertility and family planning practices in rural Bangladesh.
  292. Nurses in family planning: counseling, patient advocacy, and clinical care. 3rd revision.
  293. Nutrition and contraceptive steroids [letter]
  294. Nutrition care in family planning. A guide for administrators.
  295. Nutrition, family planning and health components of the Guatemalan Program of Primary Health Care (SINAPS)
  296. Nutritional status of women attending family planning clinics.
  297. On evaluating "natural family planning" in family planning programs.
  298. On the calculation of failure rates for the so-called natural family planning methods. [uber die Berechnung der Versagerquote bei den Methoden der sogenannten naturlichen Familienplanung.]
  299. Operational plan for a contraceptive retail sales project in Pakistan.
  300. Operations Research in Family Planning: an evaluation of Contract AID/DSPE-C-0055, the Johns Hopkins University.
  301. Opportunities for private sector family planning information and service activities in Kenya.
  302. Oral and vaginal candida colonization under the influence of hormonal contraception (author's transl) [Die orale und vaginale Besiedlung mit Candida albicans unter dem Einfluss hormonaler Kontrazeption.]
  303. Oral contraception and cardiovascular risk (author's transl) [Orale Kontrazeption und kardiovaskulares Risiko.]
  304. Oral contraception and some debatable side effects.
  305. Oral contraception and troleandomycin (author's transl) [Contraception orale et troleandomycine. Un nouveau cas d'ictere.]
  306. Oral contraception in 1983 (author's transl) [Le point sur la contraception orale en 1983.]
  307. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception.
  308. Oral contraception in patients with hyperprolactinaemia.
  309. Oral contraception, Budd-Chiari syndrome and antibodies to synthetic sex hormones.
  310. Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis.
  311. Oral contraception.
  312. Oral contraceptive labeling disclosure of possible benefits.
  313. The oral contraceptive pill: use, user satisfaction, side effects and fears among Manawatu women.
  314. Oral contraceptive steroid plasma concentrations in smokers and non-smokers (author's transl) [Concentrations plasmatiques des contraceptifs steroidiens oraux chez les fumeuses et les non fumeuses.]
  315. Oral contraceptive steroids and malignancy [editorial]
  316. Oral contraceptive use and abortion before first term pregnancy in relation to breast cancer risk.
  317. Oral contraceptive use and the risk of endometrial cancer.
  318. Oral contraceptive use and the risk of ovarian cancer: the Centers for Disease Control Cancer and Steroid Hormone Study.
  319. Oral contraceptive use, the menstrual cycle, and the need for sleep.
  320. The oral contraceptive: past, present and future use.
  321. Oral contraceptives abolish luteal phase exacerbation of hyperglycemia in type 1 diabetes [letter]
  322. Oral contraceptives and arterial disease.
  323. Oral contraceptives and breast cancer.
  324. Oral contraceptives and cancer of the liver: a review with two additional cases.
  325. Oral contraceptives and cancer risk.
  326. Oral contraceptives and cardiovascular disease [letter]
  327. Oral contraceptives and cardiovascular disease [letter]
  328. Oral contraceptives and cardiovascular disease: some questions and answers.
  329. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
  330. Oral contraceptives and diabetes mellitus. [P-piller og diabetes mellitus.]
  331. Oral contraceptives and erythema nodosum. Report of a case.
  332. Oral contraceptives and fibrinolysis among female cyclists before and after exercise.
  333. Oral contraceptives and gallbladder disease. Royal College of General Practitioners' Oral Contraception Study.
  334. Oral contraceptives and hepatic tumours.
  335. Oral contraceptives and hepatocellular carcinoma.
  336. Oral contraceptives and lipids.
  337. Oral contraceptives and MI: how strong is the link?
  338. Oral contraceptives and postoperative venous thrombosis.
  339. Oral contraceptives and the dental practitioner.
  340. Oral contraceptives and vascular disease.
  341. Oral contraceptives have beneficial effects.
  342. Oral contraceptives in the public sector: a sales training manual.
  343. Oral contraceptives postdatism as a complication.
  344. Oral contraceptives, clotting factors, and thrombosis.
  345. Oral contraceptives, smoking and risk of myocardial infarction in young women. A longitudinal population study in eastern Finland.
  346. Oral contraceptives, smoking, and cardiovascular disease: response to F.M. Sturtevant.
  347. Oral contraceptives.
  348. Oral contraceptives.
  349. Oral contraceptives. Clinical pharmacology, pharmacokinetics and drug interactions (author's transl) [Orale Knotrazeptiva. Klinische Pharmakologie, Pharmakokinetik und Arzneimittelinteraktionen.]
  350. Oral contraceptives. Vol. 6.
  351. Oral contraceptives: effects on folate and vitamin B12 metabolism.
  352. Oral contraceptives: technical and safety aspects.

     

  353. Oral contraceptives: the risks and benefits.
  354. Oral contraceptives: where are the excess deaths?
  355. Oral cytological studies on the effect of contraceptive compound preparations as compared to menstruation and pregnancy. [Oral-zytologische Untersuchungen zum Einfluss kontrazeptiver Kombinationspraparate im Vergleich zu Menstruation and Schwangerschaft.]
  356. Oral rehydration for the treatment of diarrhea: its value as a health component in community based family planning distribution programs.
  357. Organization for change: a systems analysis of family planning in rural India.
  358. Our experience of four years of intrauterine contraception (2997 insertions of the No-Gravid intrauterine device)
  359. Our experience of the use of the No Gravid device as an intrauterine contraceptive.
  360. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
  361. An overview of the integrated project for family planning, nutrition and parasite control.
  362. Ovulation suppression in women following vaginal administration of oral contraceptive tablets.
  363. Parasite Control in the Integrated Family Planning, Nutrition and Parasite Control Program.
  364. Parent-child communication in family planning in a middle class block in Bangalore city.
  365. Patterns of contraceptive use among female adolescents: method consistency in a clinic setting.
  366. Patterns of contraceptive use in Kingston and St. Andrew, Jamaica, 1970-1977.
  367. Paying for the pill: side effects associated with oral contraceptives.
  368. Peliosis hepatis and oral contraceptives: a case report.
  369. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
  370. Perceptions of efficacy and control, and contraceptive behavior.
  371. Personhood and the contraceptive right.
  372. A perspective on progestogens in oral contraceptives.
  373. Perspectives on vaginal contraception: a method for the 1980s.
  374. Pharmacy, contraception and the health care role.
  375. Phlegmasia cerulea dolens as a complication of short-course oral contraceptives for dysfunctional bleeding.
  376. Piaui State, Brasil 1979-1981: growth of a program for community-based distribution of family planning.
  377. Piaui State, Brasil 1979-1981: growth of a program for community-based distribution of family planning.
  378. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
  379. A plan to assess the utility of pictorial print materials in providing method-specific information and support for contraceptive continuation. Evaluation sites: Botswana, Sierra Leone.
  380. Planned Parenthood and Women's Development: the IPPF experience.
  381. Planned Parenthood continues prescribing birth control for teens.
  382. Planned Parenthood Federation of Nigeria (National Headquarters) Lagos. Operational Guidelines No. 4. PPFN Fieldwork Programme.
  383. Planned Parenthood Federation of Nigeria. 1981 Annual Report.
  384. Planned Parenthood Federation of Nigeria. Executive Director's Annual Report, 1982.
  385. Planned parenthood: an instrument of social change.
  386. Plasma and erythrocyte membrane fatty acids in oral contraceptive users.
  387. Platelet aggregation in response to 5-HT in migraine patients taking oral contraceptives [letter]
  388. Policies and practices in the provision of contraceptive methods during breast-feeding and support of breast-feeding.
  389. The politics of family planning in the Maghrib.
  390. The politics of fertility control: family planning policy in the Philippines.
  391. Population and family planning activities undertaken in the ESCAP Region by IPPF and financial and technical assistance to national population/family planning programs.
  392. Population and family planning programs; a compendium of data through 1981. 11th ed.
  393. Population and family planning research, Bangladesh: an annotated bibliography.
  394. The population explosion and family planning: elements of a policy to defend the quality of life in Portugal. [Explosao demografica e planeamento familiar: subsidios para uma politica de defesa da vida em Portugal.]
  395. Population growth and contraception in Africa [letter]
  396. Population growth and contraception in Africa [letter]
  397. Population growth and contraception in Africa [letter]
  398. Population growth and contraception in Africa [letter]
  399. Population growth and contraception in Africa [letter]
  400. Population growth and family planning in Brazil. [Crescimento populacional e planejamento familiar no Brasil.]
  401. Population information: politics and policy. Proceedings of the Fourteenth Annual Conference, Association for Population/Family Planning Libraries and Information Centers--International, Washington Hilton Hotel, Washington, D.C., 23-26 March 1981.
  402. Population policy and family planning communication strategies in the Arab states region. Vol. 2. State of the art in the Arab world.
  403. Population problems and family planning in five countries: a transcultural reconnaissance. Japan, Egypt, Puerto Rico, Bangladesh, Kenya.
  404. Portal and superior mesenteric venous thrombosis secondary to oral contraceptive treatment. Two cases (author's transl) [Thromboses veineuses portale et mesenterique superieure, secondaires a un traitement contraceptof oral. A propos de duex cas.]
  405. Post coital contraception (or morning-after contraception) [La contraception post-coitale (ou contraception du lendemain)]
  406. Post-partum and sexuality and contraception.
  407. Postabortion and postpartum contraception. [Contraception apres avortement et apres accouchement.]
  408. Postcoital contraception (editorial) [Postkoitale Kontrasepsie.]
  409. Postcoital contraception (letter) [Postkoitale Kontrasepsie.]
  410. Postcoital contraception for unprotected intercourse.
  411. Postcoital contraception in England. [La contraception post-coitale en Angleterre.]
  412. Postcoital contraception. [Postkoitale kontrazeption.]
  413. Postcoital contraception. An introduction to "morning-after" methods of birth control.
  414. Postpartum and postabortion contraception. [Contraception apres accouchement et apres IVG.]
  415. Potency of progestogens in oral contraceptives. Further delay of menses data.
  416. Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data. [Interet potentiel des preparations oestroprogestatives triphasiques en fonction des donnees epidemiologiques et endocrinometaboliques recentes.]
  417. Potential contraception by interference with capacitation.
  418. Practicing prevention: contraception.
  419. A preference study on the acceptability of oral contraceptives in their two forms: tablets and paper pills.
  420. Pregnancy, contraception and the family-planning clinic: from the woman's point of view (studies of 3635 puerperas in 6 Lombard hospital obstetrical departments. [La gravidanza, la contraccezione, il consultorio: cosi li vede la donna. (Indagine su 3,635 puerpere in 6 Sale Parto lombarde)]
  421. A preliminary report on the intracervical contraceptive device--its effect on cervical mucus.
  422. Premenstrual complaints. Influence of oral contraceptives (author's transl) [Syndrome premenstruel. Influence des contraceptifs oraux.]
  423. The Prentif contraceptive cervical cap: a contemporary study of its clinical safety and effectiveness.
  424. Prevalence of contraceptive use during lactation in developing countries.
  425. The prevalence of natural family planning through the results of WFS surveys.
  426. Prevalence, continuation and availability of contraceptive methods: a summary of the results of the Egypt Contraceptive Prevalence Survey.
  427. Print materials for nonreaders: experiences in family planning and health.
  428. Priority needs of social science research in family planning.
  429. The progestogen-only contraceptive pill [review article]
  430. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
  431. Prognosis of pathological menstrual bleeding caused by the intrauterine contraceptive device "Umbrella" by immunochemical determination of some components of the fibrinolytic system. [Prognozirovanie razlichnykh patologicheskikh menstrual'nykh krovotechenij pri primenenii vnutrimatochnogo kontratseptiva "Zontik" s pomoshch'iu immunokhimicheskogo opredeleniia nekotorykh komponentov fibrinoliticheskoj sistemy.]
  432. Program performance: the assessment of Asian family planning programs.
  433. Project identification document: India--family planning.
  434. Project of aides-familiales, Le Kef. Evaluation study of a rural health and family planning project in Tunisia, March 1978-March 1981. [Projet des aides-familiales Le Kef: etude d'evaluation d'un projet d'hygiene rurale et de planification familiale en Tunisie Mars 1978-Mars 1981.]
  435. Project paper: Kenya family planning ii. Project 615-0193.
  436. Prolactin levels and the response to central dopamine synthesis blockade in subjects on oral contraceptives.
  437. Protection against endometrial carcinoma by combination-product oral contraceptives [letter]
  438. Providing family planning for unreached groups.
  439. Providing family planning programs to the Indochinese refugees in the Philadelphia area.
  440. The provision of birth control services to unwed minors: a national survey of physician attitudes and practices.
  441. Psychiatric complications after surgical contraception.
  442. Psychiatric side effects of oral contraceptives (preliminary results) [Psychische Nebenwirkungen oraler Kontrazeptiva. (Vorlaufige Ergebnisse)]
  443. Psychological approach to voluntary termination of pregnancy. The responsible control of fertility. Risks and obstacles to effective contraception. [Approche psychologique de l'interruption volontaire de grossesse. II. Le controle responsable de la fecondite. Aleas et obstacles a la contraception.]
  444. Psychological aspects of contraception. [Les aspects psychologiques de la contraception.]
  445. Psychological aspects of family planning. [Aspectos psicologicos do planejamento familiar.]
  446. Psychological barriers to contraceptive use among adolescent women.
  447. A psychological investigation of contraceptive behavior.
  448. Psychological issues arising from the development of new male contraceptives [letter]
  449. Psychological issues arising from the development of new male contraceptives.
  450. Psychosexual issues in adolescent contraception.
  451. Psychosocial determinants of contraception: a conceptual model.
  452. Psychosomatic effects of oral contraception. [Effetti psicosomatici della contraccezione orale.]
  453. Public funding of contraceptive services, 1980-1982.
  454. Puerto Rico Fertility and Family Planning Assessment, 1982 [MRDF]
  455. The Puerto Rico oral contraceptive study. [editorial]
  456. Quantitative analysis of ethynodiol diacetate and ethinyl estradiol/mestranol in oral contraceptive tablets by high-performance liquid chromatography.
  457. The question of contraception: reactualization of old methods, new methods, in the study of future methods. [Le point sur la contraception: reactualisation d'anciennes methodes nouvelles methodes a l'etude methodes de demain.]
  458. Radio and family planning in Kiribati.
  459. A reassessment of intrauterine contraception.
  460. Recent advance and trends in male contraceptive techniques with comments on post vasectomy sequelae.
  461. Recent developments on the association between oral contraceptives and cardiovascular disease.
  462. Recent topics in oral contraceptives.
  463. Rectal strictures associated with the intra-uterine contraceptive device.
  464. Recurring inflammation of optic nerve after longtime therapy with hormonal contraceptive Anacyclin 28 (author's transl) [Monolaterale rezidivierende Neuritis N. optici unter Langzeittherapie mit dem hormonalen Kontrazeptivum Anacyclin 28.]
  465. Regional pattern of differentials in contraceptive use in Egypt.
  466. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use.
  467. Regulation of spermatogenesis and possible sites for contraceptive action.
  468. Relation between attitudes towards sources of information on family planning and social change during the period 1971-1980 in two Egyptian subcultures.
  469. The relationship of abortion attitudes and contraceptive behavior among young single women.
  470. The relationship of contraceptive availability to contraceptive use.
  471. Retrieval of intrauterine contraceptive device with missing tail by means of a plastic spiral curette (Mi-Mark)
  472. Return of fertility after use of the injectable contraceptive Depo-Provera: updated analysis.
  473. Reversible and permanent contraceptive methods. [Metodos anticonceptivos reversibles e irreversibles.]
  474. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use.
  475. A review on IUD (Lippes loop) as a contraceptive method in a Singapore family planning clinic, 1965-1981.
  476. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
  477. Risk factors for gall-bladder disease: a cohort study of young women attending family planning clinics.
  478. The risk of myocardial infarction in former users of oral contraceptives.
  479. The risks and benefits of oral contraceptives in the developing world. Past experiences and future perspectives.
  480. Risks in birth control. [Risiken der Fertilitatskontrolle.]
  481. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
  482. The role of communication in economic and social development in the less developed countries, with particular reference to family planning in Nigeria.
  483. The role of contraception in community-based programs.
  484. Role of employers' organisations in family welfare education and family planning activities.
  485. The role of hormonal contraception in the prevention of breast and female reproductive cancer. [Role de la contraception hormonale dans la prevention des cancers du sein et des organes genitaux feminins.]
  486. The role of Islamic information in family planning (through interpersonal communication)
  487. Role of non-governmental organizations in surgical contraception in Sri Lanka.
  488. Role of psychological variables in family planning practice.
  489. The role of Sri Lanka Association for Voluntary Surgical Contraception in voluntary surgical contraception in Sri Lanka.
  490. The role of steroids as male contraceptives.
  491. The role of surveys in the analysis of family planning programs: proceedings of a seminar held in Bogota (Colombia), 28-31 October 1980.
  492. Role of the marriage counselor in contraception. [Place de la conseillere conjugale dans la contraception.]
  493. The role of the World Federation in surgical contraception.
  494. Role, status and problems of Thai women in family planning.
  495. Round table: [has the attitude changed with regard to the benefits and risks of oral contraception]
  496. Rural Survey of Family Planning, Sept-Oct 1981. National results. [Encuesta Rural de Planificacion Familiar, Sep-Oct 1981. Resultados nacionales.]
  497. The rural world and information about contraception. [Le monde rural et l'information a la contraception.]
  498. Safety and risks of hormonal contraceptives. [Sicherheit und Risiko hormonaler Kontrazeptiva.]
  499. Safety, efficacy, and values: what family planning counselors believe.
  500. Santhaan. Kaise Rokein? Kaise Payein? A case study of the Patna Natural Family Planning Programme.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.